JOUNCE THERAPEUTICS, INC.: cashflow_financing

Value{"amount": 91995000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2021-01-01 – 2021-09-30
Statuscurrent
EntityJOUNCE THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001640455-21-000147 · Open the official SEC filing →
Retrieved: 2026-08-19T16:52:41.747109+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001640455/cashflow-financing/2021-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/7c3e954e-e12a-4028-9007-e5f05c6f6083

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies